Literature DB >> 17558682

A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2.

Seung-Hwan Lee1, Mee-Ran Kim, Ji-Hyun Kim, Hyuk-Sang Kwon, Kun-Ho Yoon, Ho-Young Son, Bong-Yun Cha.   

Abstract

We report a patient with combined polycystic ovary syndrome (PCOS) and autoimmune polyglandular syndrome (APS) type 2. A 26-year-old female presented with polyuria, polydipsia and acute weight loss. She was diagnosed with: (1) type 1 diabetes, with hyperglycemia, impaired insulin secretion, and positive autoantibodies for GAD-65 and IA-2; (2) autoimmune thyroiditis, with hypothyroidism, positive anti-microsomal and antithyroglobulin antibodies; and (3) PCOS, with hyperandrogenic signs that had developed 5 years earlier, amenorrhea for the previous 6 months, and characteristic multiple microcystic appearance of both ovaries on ultrasonography. She is being treated with multiple subcutaneous insulin injections, thyroxine replacement, and cyclic medroxyprogesterone for the aforementioned diseases, respectively. Although several investigations have reported a relationship between PCOS and the individual components of APS, this is the first report of both syndromes occurring simultaneously. Potential mechanisms for their interrelation and the possibility that PCOS is an autoimmune disease are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17558682     DOI: 10.1080/09513590701297658

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  2 in total

1.  Association of polycystic ovary syndrome and Graves' disease: Is autoimmunity the link between the two diseases.

Authors:  Sobia Nisar; Parvez A Shah; M Shafi Kuchay; Manzoor A Bhat; Aafia Rashid; Sanjeed Ahmed; Mohd Ashraf Ganie
Journal:  Indian J Endocrinol Metab       Date:  2012-11

2.  Anti-Nuclear Antibodies in Patients with Polycystic Ovary Syndrome before and after Laparoscopic Electrocauterization.

Authors:  Alamtaj Samsami Dehaghani; Nazanin Karimaghaei; Mohammad Ebrahim Parsanezhad; Mahyar Malekzadeh; Mohammad Mehrazmay; Nasrollah Erfani
Journal:  Iran J Med Sci       Date:  2013-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.